If they purchased shares in this deal AND excercized all allowed warrants their base cost for the common and shares purchased with warrants would be .57. However, no one is going to excercise warrants unless and until the price exceeds .70 at time of execution.

For now it is just 70 million shares at .50 that need to be sold. You'd be buying shares at a near 20% premium over the current PPS so you would really have to believe we'll see north of .70 in the next 12 months to want to buy in.

That's what makes me think someone needs to create a buzz so they can move these shares. The underwriter is only concerned with the 70 million at .50 to cover their funds to Crystallex. They must be able to sell theseand fairly quickly to make this deal worthwhile for them.

Maybe some milestone information will be announced shortly afterword? I'd say the underwriter must have some kind of assurance if they are going through with this as currently listed.